Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 1473 | 47.38 |
09:34 ET | 1500 | 47.27 |
09:36 ET | 400 | 47.265 |
09:38 ET | 12603 | 47.49 |
09:39 ET | 2351 | 47.97 |
09:41 ET | 2000 | 48.05 |
09:43 ET | 1150 | 48.3 |
09:45 ET | 2141 | 48.47 |
09:48 ET | 3109 | 48.455 |
09:50 ET | 1200 | 48.57 |
09:52 ET | 3236 | 48.58 |
09:54 ET | 1570 | 48.59 |
09:56 ET | 2350 | 48.55 |
09:57 ET | 3650 | 48.41 |
09:59 ET | 361 | 48.39 |
10:01 ET | 6905 | 48.6 |
10:03 ET | 3755 | 48.8 |
10:06 ET | 2831 | 48.86 |
10:08 ET | 2100 | 48.74 |
10:10 ET | 2300 | 48.84 |
10:12 ET | 1554 | 48.74 |
10:14 ET | 1150 | 48.61 |
10:15 ET | 4879 | 48.52 |
10:17 ET | 3912 | 48.52 |
10:19 ET | 2700 | 48.535 |
10:21 ET | 2729 | 48.545 |
10:24 ET | 6252 | 48.48 |
10:26 ET | 2827 | 48.59 |
10:28 ET | 3437 | 48.63 |
10:30 ET | 500 | 48.575 |
10:32 ET | 600 | 48.565 |
10:33 ET | 5649 | 48.39 |
10:35 ET | 2152 | 48.435 |
10:37 ET | 1870 | 48.57 |
10:39 ET | 13732 | 48.72 |
10:42 ET | 15556 | 48.965 |
10:44 ET | 850 | 49.12 |
10:46 ET | 700 | 49.13 |
10:48 ET | 800 | 49.31 |
10:50 ET | 2503 | 49.32 |
10:51 ET | 11585 | 49.04 |
10:53 ET | 3163 | 49.03 |
10:55 ET | 11628 | 49.095 |
10:57 ET | 1200 | 49.105 |
11:00 ET | 1479 | 49.095 |
11:02 ET | 700 | 49.095 |
11:04 ET | 6150 | 49 |
11:06 ET | 10455 | 49 |
11:08 ET | 19786 | 49.02 |
11:09 ET | 5440 | 48.93 |
11:11 ET | 3326 | 48.99 |
11:13 ET | 1284 | 49.0122 |
11:15 ET | 1318 | 49.02 |
11:18 ET | 1057 | 48.985 |
11:20 ET | 46537 | 49 |
11:22 ET | 3251 | 49.08 |
11:24 ET | 2393 | 49.18 |
11:26 ET | 600 | 49.12 |
11:27 ET | 900 | 49.135 |
11:29 ET | 6214 | 49.21 |
11:31 ET | 1860 | 49.08 |
11:33 ET | 699 | 49.08 |
11:36 ET | 2595 | 49.08 |
11:38 ET | 1743 | 49.04 |
11:40 ET | 1023 | 48.98 |
11:42 ET | 19245 | 49.03 |
11:44 ET | 31168 | 49.03 |
11:45 ET | 4279 | 49.04 |
11:47 ET | 1148 | 49.03 |
11:49 ET | 4863 | 49.1 |
11:51 ET | 1995 | 49.16 |
11:54 ET | 916 | 49.13 |
11:56 ET | 881 | 49.11 |
11:58 ET | 200 | 49.125 |
12:00 ET | 2233 | 49.19 |
12:02 ET | 700 | 49.19 |
12:03 ET | 3283 | 49.34 |
12:05 ET | 2288 | 49.43 |
12:07 ET | 2604 | 49.36 |
12:09 ET | 650 | 49.39 |
12:12 ET | 200 | 49.35 |
12:14 ET | 400 | 49.22 |
12:16 ET | 200 | 49.22 |
12:18 ET | 1278 | 49.1 |
12:20 ET | 11852 | 49.09 |
12:21 ET | 12746 | 49.12 |
12:23 ET | 1216 | 49.09 |
12:25 ET | 822 | 49.06 |
12:27 ET | 206 | 49.06 |
12:30 ET | 300 | 49.06 |
12:32 ET | 2347 | 49.13 |
12:34 ET | 1708 | 49.11 |
12:36 ET | 822 | 49.07 |
12:39 ET | 100 | 49.065 |
12:41 ET | 1327 | 49.05 |
12:43 ET | 1241 | 49 |
12:45 ET | 733 | 49.035 |
12:48 ET | 7605 | 49.405 |
12:50 ET | 1403 | 49.44 |
12:52 ET | 600 | 49.39 |
12:54 ET | 100 | 49.33 |
12:56 ET | 911 | 49.32 |
12:57 ET | 4160 | 49.52 |
12:59 ET | 926 | 49.51 |
01:01 ET | 700 | 49.45 |
01:03 ET | 100 | 49.47 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 8.6B | -31.5x | --- |
Ascendis Pharma A/S | 8.9B | -15.3x | --- |
Intra-Cellular Therapies Inc | 7.7B | -85.7x | --- |
Tempus AI Inc | 8.0B | -6.5x | --- |
Revolution Medicines Inc | 7.3B | -12.3x | --- |
Blueprint Medicines Corp | 5.6B | -27.5x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.6B |
---|---|
Revenue (TTM) | $456.0M |
Shares Outstanding | 184.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.10 |
EPS | $-1.57 |
Book Value | $6.88 |
P/E Ratio | -31.5x |
Price/Sales (TTM) | 18.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.